<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3309948&amp;fmt=gif">
vector

Nominate a Qualified Member to Join our Virtual Blue Zone.

We welcome referrals for visionary entrepreneurs, founders, and investors who are committed to maximizing their healthspan and staying at the cutting edge of the longevity space.

You’re invited to submit as many nominations as you'd like for friends or colleagues who would both contribute to—and benefit from—the Abundance Longevity trip experience. Nominations are reviewed on a rolling basis.

Thank you for helping to elevate the Abundance Community!

 

platinum_exp

THIS IS FOR PEOPLE YOU KNOW INTERESTED IN:

icon_Bar Chart

INVESTMENT ACCESS

Direct entry to pre-market opportunities in the most compelling biotech sector of the decade. Meet founders, evaluate technologies, and secure allocations in breakthrough startups before they reach mainstream investors.

DNA+magGlass

HEALTH OPTIMIZATION

Personalized pathways to address specific health conditions for yourself or loved ones. Gain privileged access to advanced diagnostics, clinical trials, and emerging therapeutics typically unavailable to the public.

Head+Burst

TRANSFORMATIVE INSIGHTS

Engage in private conversations with Harvard researchers, biotech visionaries, and Nobel laureates leading the longevity revolution. These relationships become part of your ongoing journey.

vector

About Your Host

PETER H. DIAMANDIS, MD

Peter is a serial entrepreneur, futurist, technologist, New York Times bestselling author, and the founder of over 25 companies.

He is a pioneer in the longevity world, having co-founded Fountain Life, Lifeforce, Human Longevity Inc., Cellularity, and Vaxxinity. Fortune Magazine has named Peter "one of the World's 50 Greatest Leaders." He is the Founder and Executive Chairman of the XPRIZE Foundation, which has launched over $600M of incentive competitions (including the $101M XPRIZE Healthspan).

Peter's venture fund, BOLD Capital Partners, is deploying $600M+ into longevity startups and exponential tech. He has written 6 books including 4 New York Times bestsellers. Peter received his BS and MS from MIT, and his MD from Harvard Medical School.

PETER H. DIAMANDIS, MD

“I think one day maybe we can cure all disease with the help of AI. Maybe within the next decade or so.”

— Demis Hassabis, PhD, CEO of Google DeepMind and Nobel Prize Winner